Europe Human Growth Hormone Market By Application (Small for Gestational Age, Prader-Willi Syndrome, Idiopathic Short Stature, Turner Syndrome, Growth Hormone Deficiency and Other Applications) By Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Specialty Pharmacy and Online Pharmacy) By Country, Industry Analysis and Forecast, 2019 - 2025
The Europe Human Growth Hormone Market would witness market growth of 7.9% CAGR during the forecast period (2019-2025).
In addition, initiatives taken by various government and private organizations to raise awareness of GH deficiencies and human growth hormone therapy are expected to drive the market. Every year, the International Coalition of Organizations Supporting Endocrine Patients (ICOSEP), celebrates International Children's Growth Awareness Day to raise awareness about early diagnosing and treating growth hormone disorders among humans, particularly children. Nevertheless, the high cost of HGH treatment and the multiple adverse effects associated with HGH could impede market growth over the forecast period. For example, as per UPMC Children's Hospital in Pittsburgh, potential side effects of GH hormone therapy are hip, knee, or other joint pain; allergic reactions, including rash, swelling, or hives; and increased blood sugar levels.
The human growth hormone is very common among bodybuilders and athletes due to the many benefits it offers. Besides burning fat, it is also very effective for muscle building. Because of a possible muscle growth and strength benefit, bodybuilders and athletes who have been tempted to take performance-enhancing drugs and supplements such as steroids have taken HGH to achieve an athletic advantage, or for rapid, aesthetic muscle growth. Because digestion can break down HGH taken orally, it is injected when it is used as a supplementary drug. The bodybuilding industry was the first to find that HGH wasn't just some drug to help growing children. This industry was also the first to quickly understand HGH's anabolic properties and it could help them in achieving their only goal of a huge, youthful, well-ripped body.
Based on Application, the market is segmented into Small for Gestational Age, Prader-Willi Syndrome, Idiopathic Short Stature, Turner Syndrome, Growth Hormone Deficiency and Other Applications. Based on the type of Growth Hormone Deficiency, the application of Human Growth Hormone is studied across Pediatric Growth Hormone Deficiency and Adult Growth Hormone Deficiency. Based on Distribution Channel, the market is segmented into Retail Pharmacy, Hospital Pharmacy, Specialty Pharmacy and Online Pharmacy. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Merck Group, Teva Pharmaceuticals Industries Ltd., Ipsen Pharma Biotech SAS, Novartis AG (Sandoz International GmbH), Pfizer, Inc., F. Hoffmann-La Roche Ltd. (Genentech, Inc.), Ferring Holdings SA, Novo Nordisk A/S, Eli Lilly and Company, and Anhui Anke Biotechnology Group Co., Ltd.
Scope of the Study
Market Segmentation:
By Application
In addition, initiatives taken by various government and private organizations to raise awareness of GH deficiencies and human growth hormone therapy are expected to drive the market. Every year, the International Coalition of Organizations Supporting Endocrine Patients (ICOSEP), celebrates International Children's Growth Awareness Day to raise awareness about early diagnosing and treating growth hormone disorders among humans, particularly children. Nevertheless, the high cost of HGH treatment and the multiple adverse effects associated with HGH could impede market growth over the forecast period. For example, as per UPMC Children's Hospital in Pittsburgh, potential side effects of GH hormone therapy are hip, knee, or other joint pain; allergic reactions, including rash, swelling, or hives; and increased blood sugar levels.
The human growth hormone is very common among bodybuilders and athletes due to the many benefits it offers. Besides burning fat, it is also very effective for muscle building. Because of a possible muscle growth and strength benefit, bodybuilders and athletes who have been tempted to take performance-enhancing drugs and supplements such as steroids have taken HGH to achieve an athletic advantage, or for rapid, aesthetic muscle growth. Because digestion can break down HGH taken orally, it is injected when it is used as a supplementary drug. The bodybuilding industry was the first to find that HGH wasn't just some drug to help growing children. This industry was also the first to quickly understand HGH's anabolic properties and it could help them in achieving their only goal of a huge, youthful, well-ripped body.
Based on Application, the market is segmented into Small for Gestational Age, Prader-Willi Syndrome, Idiopathic Short Stature, Turner Syndrome, Growth Hormone Deficiency and Other Applications. Based on the type of Growth Hormone Deficiency, the application of Human Growth Hormone is studied across Pediatric Growth Hormone Deficiency and Adult Growth Hormone Deficiency. Based on Distribution Channel, the market is segmented into Retail Pharmacy, Hospital Pharmacy, Specialty Pharmacy and Online Pharmacy. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Merck Group, Teva Pharmaceuticals Industries Ltd., Ipsen Pharma Biotech SAS, Novartis AG (Sandoz International GmbH), Pfizer, Inc., F. Hoffmann-La Roche Ltd. (Genentech, Inc.), Ferring Holdings SA, Novo Nordisk A/S, Eli Lilly and Company, and Anhui Anke Biotechnology Group Co., Ltd.
Scope of the Study
Market Segmentation:
By Application
- Small for Gestational Age
- Prader-Willi Syndrome
- Idiopathic Short Stature
- Turner Syndrome
- Growth Hormone Deficiency and
- Pediatric Growth Hormone Deficiency
- Adult Growth Hormone Deficiency
- Other Applications
- Retail Pharmacy
- Hospital Pharmacy
- Specialty Pharmacy
- Online Pharmacy
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Merck Group
- Teva Pharmaceuticals Industries Ltd.
- Ipsen Pharma Biotech SAS
- Novartis AG (Sandoz International GmbH)
- Pfizer, Inc.
- F. Hoffmann-La Roche Ltd. (Genentech, Inc.)
- Ferring Holdings SA
- Novo Nordisk A/S
- Eli Lilly and Company
- Anhui Anke Biotechnology Group Co., Ltd.
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Human Growth Hormone Market, by Application
1.4.2 Europe Growth Hormone Deficiency Application Market, by Type
1.4.3 Europe Human Growth Hormone Market, by Distribution Channel
1.4.4 Europe Human Growth Hormone Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. EUROPE HUMAN GROWTH HORMONE MARKET BY APPLICATION
3.1 Europe Small for Gestational Age Market by Country
3.2 Europe Prader-Willi Syndrome Market by Country
3.3 Europe Idiopathic Short Stature Market by Country
3.4 Europe Turner Syndrome Market by Country
3.5 Europe Growth Hormone Deficiency Market by Country
3.5.1 Europe Growth Hormone Deficiency Application Market by Type
3.5.1.1 Europe Pediatric Growth Hormone Deficiency Market by Country
3.5.1.2 Europe Adult Growth Hormone Deficiency Market by Country
3.6 Europe Other Applications Market by Country
CHAPTER 4. EUROPE HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL
4.1 Europe Retail Pharmacy Market by Country
4.2 Europe Hospital Pharmacy Market by Country
4.3 Europe Specialty Pharmacy Market by Country
4.4 Europe Online Pharmacy Market by Country
CHAPTER 5. EUROPE HUMAN GROWTH HORMONE MARKET BY COUNTRY
5.1 Germany Human Growth Hormone Market
5.1.1 Germany Human Growth Hormone Market by Application
5.1.1.1 Germany Growth Hormone Deficiency Application Market by Type
5.1.2 Germany Human Growth Hormone Market by Distribution Channel
5.2 UK Human Growth Hormone Market
5.2.1 UK Human Growth Hormone Market by Application
5.2.1.1 UK Growth Hormone Deficiency Application Market by Type
5.2.2 UK Human Growth Hormone Market by Distribution Channel
5.3 France Human Growth Hormone Market
5.3.1 France Human Growth Hormone Market by Application
5.3.1.1 France Growth Hormone Deficiency Application Market by Type
5.3.2 France Human Growth Hormone Market by Distribution Channel
5.4 Russia Human Growth Hormone Market
5.4.1 Russia Human Growth Hormone Market by Application
5.4.1.1 Russia Growth Hormone Deficiency Application Market by Type
5.4.2 Russia Human Growth Hormone Market by Distribution Channel
5.5 Spain Human Growth Hormone Market
5.5.1 Spain Human Growth Hormone Market by Application
5.5.1.1 Spain Growth Hormone Deficiency Application Market by Type
5.5.2 Spain Human Growth Hormone Market by Distribution Channel
5.6 Italy Human Growth Hormone Market
5.6.1 Italy Human Growth Hormone Market by Application
5.6.1.1 Italy Growth Hormone Deficiency Application Market by Type
5.6.2 Italy Human Growth Hormone Market by Distribution Channel
5.7 Rest of Europe Human Growth Hormone Market
5.7.1 Rest of Europe Human Growth Hormone Market by Application
5.7.1.1 Rest of Europe Growth Hormone Deficiency Application Market by Type
5.7.2 Rest of Europe Human Growth Hormone Market by Distribution Channel
CHAPTER 6. COMPANY PROFILES
6.1 Merck Group
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Geographical Expansions:
6.2 Teva Pharmaceutical Industries Ltd.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expenses
6.2.5 Recent strategies and developments:
6.2.5.1 Product Launches and Product Expansions:
6.3 Ipsen Pharma Biotech SAS
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Partnerships, Collaborations, and Agreements:
6.3.5.2 Product Launches and Product Expansions:
6.3.5.3 Approvals:
6.4 Novartis AG (Sandoz International GmbH)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.4.5 Recent strategies and developments:
6.4.5.1 Partnerships, Collaboration, and Agreements:
6.4.5.2 Product Launches and Product Expansions:
6.5 Pfizer, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.6 F. Hoffmann-La Roche Ltd. (Genentech, Inc.)
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.7 Ferring Holdings SA
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Research & Development Expenses
6.8 Novo Nordisk A/S
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental & Regional Analysis
6.8.4 Research & Development Expenses
6.9 Eli Lilly and Company
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Regional Analysis
6.9.4 Research & Development Expense
6.1 Anhui Anke Biotechnology Group Co., Ltd.
6.10.1 Company Overview
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Human Growth Hormone Market, by Application
1.4.2 Europe Growth Hormone Deficiency Application Market, by Type
1.4.3 Europe Human Growth Hormone Market, by Distribution Channel
1.4.4 Europe Human Growth Hormone Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. EUROPE HUMAN GROWTH HORMONE MARKET BY APPLICATION
3.1 Europe Small for Gestational Age Market by Country
3.2 Europe Prader-Willi Syndrome Market by Country
3.3 Europe Idiopathic Short Stature Market by Country
3.4 Europe Turner Syndrome Market by Country
3.5 Europe Growth Hormone Deficiency Market by Country
3.5.1 Europe Growth Hormone Deficiency Application Market by Type
3.5.1.1 Europe Pediatric Growth Hormone Deficiency Market by Country
3.5.1.2 Europe Adult Growth Hormone Deficiency Market by Country
3.6 Europe Other Applications Market by Country
CHAPTER 4. EUROPE HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL
4.1 Europe Retail Pharmacy Market by Country
4.2 Europe Hospital Pharmacy Market by Country
4.3 Europe Specialty Pharmacy Market by Country
4.4 Europe Online Pharmacy Market by Country
CHAPTER 5. EUROPE HUMAN GROWTH HORMONE MARKET BY COUNTRY
5.1 Germany Human Growth Hormone Market
5.1.1 Germany Human Growth Hormone Market by Application
5.1.1.1 Germany Growth Hormone Deficiency Application Market by Type
5.1.2 Germany Human Growth Hormone Market by Distribution Channel
5.2 UK Human Growth Hormone Market
5.2.1 UK Human Growth Hormone Market by Application
5.2.1.1 UK Growth Hormone Deficiency Application Market by Type
5.2.2 UK Human Growth Hormone Market by Distribution Channel
5.3 France Human Growth Hormone Market
5.3.1 France Human Growth Hormone Market by Application
5.3.1.1 France Growth Hormone Deficiency Application Market by Type
5.3.2 France Human Growth Hormone Market by Distribution Channel
5.4 Russia Human Growth Hormone Market
5.4.1 Russia Human Growth Hormone Market by Application
5.4.1.1 Russia Growth Hormone Deficiency Application Market by Type
5.4.2 Russia Human Growth Hormone Market by Distribution Channel
5.5 Spain Human Growth Hormone Market
5.5.1 Spain Human Growth Hormone Market by Application
5.5.1.1 Spain Growth Hormone Deficiency Application Market by Type
5.5.2 Spain Human Growth Hormone Market by Distribution Channel
5.6 Italy Human Growth Hormone Market
5.6.1 Italy Human Growth Hormone Market by Application
5.6.1.1 Italy Growth Hormone Deficiency Application Market by Type
5.6.2 Italy Human Growth Hormone Market by Distribution Channel
5.7 Rest of Europe Human Growth Hormone Market
5.7.1 Rest of Europe Human Growth Hormone Market by Application
5.7.1.1 Rest of Europe Growth Hormone Deficiency Application Market by Type
5.7.2 Rest of Europe Human Growth Hormone Market by Distribution Channel
CHAPTER 6. COMPANY PROFILES
6.1 Merck Group
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Segmental and Regional Analysis
6.1.4 Research & Development Expense
6.1.5 Recent strategies and developments:
6.1.5.1 Geographical Expansions:
6.2 Teva Pharmaceutical Industries Ltd.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Regional Analysis
6.2.4 Research & Development Expenses
6.2.5 Recent strategies and developments:
6.2.5.1 Product Launches and Product Expansions:
6.3 Ipsen Pharma Biotech SAS
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent strategies and developments:
6.3.5.1 Partnerships, Collaborations, and Agreements:
6.3.5.2 Product Launches and Product Expansions:
6.3.5.3 Approvals:
6.4 Novartis AG (Sandoz International GmbH)
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.3 Segmental and Regional Analysis
6.4.4 Research & Development Expense
6.4.5 Recent strategies and developments:
6.4.5.1 Partnerships, Collaboration, and Agreements:
6.4.5.2 Product Launches and Product Expansions:
6.5 Pfizer, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.4 Research & Development Expense
6.6 F. Hoffmann-La Roche Ltd. (Genentech, Inc.)
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expense
6.7 Ferring Holdings SA
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Research & Development Expenses
6.8 Novo Nordisk A/S
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental & Regional Analysis
6.8.4 Research & Development Expenses
6.9 Eli Lilly and Company
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Regional Analysis
6.9.4 Research & Development Expense
6.1 Anhui Anke Biotechnology Group Co., Ltd.
6.10.1 Company Overview
LIST OF TABLES
TABLE 1 EUROPE HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 2 EUROPE HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 3 EUROPE HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 4 EUROPE HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 5 EUROPE SMALL FOR GESTATIONAL AGE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 6 EUROPE SMALL FOR GESTATIONAL AGE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 7 EUROPE PRADER-WILLI SYNDROME MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 8 EUROPE PRADER-WILLI SYNDROME MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 9 EUROPE IDIOPATHIC SHORT STATURE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 EUROPE IDIOPATHIC SHORT STATURE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 EUROPE TURNER SYNDROME MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 EUROPE TURNER SYNDROME MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 EUROPE GROWTH HORMONE DEFICIENCY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 EUROPE GROWTH HORMONE DEFICIENCY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 EUROPE GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 16 EUROPE GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 17 EUROPE PEDIATRIC GROWTH HORMONE DEFICIENCY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 18 EUROPE PEDIATRIC GROWTH HORMONE DEFICIENCY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 19 EUROPE ADULT GROWTH HORMONE DEFICIENCY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 20 EUROPE ADULT GROWTH HORMONE DEFICIENCY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 21 EUROPE OTHER APPLICATIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 22 EUROPE OTHER APPLICATIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 23 EUROPE HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 24 EUROPE HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 25 EUROPE RETAIL PHARMACY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 26 EUROPE RETAIL PHARMACY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 27 EUROPE HOSPITAL PHARMACY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 28 EUROPE HOSPITAL PHARMACY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 29 EUROPE SPECIALTY PHARMACY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 30 EUROPE SPECIALTY PHARMACY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 31 EUROPE ONLINE PHARMACY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 32 EUROPE ONLINE PHARMACY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 33 EUROPE HUMAN GROWTH HORMONE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 34 EUROPE HUMAN GROWTH HORMONE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 35 GERMANY HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 36 GERMANY HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 37 GERMANY HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 38 GERMANY HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 39 GERMANY GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 40 GERMANY GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 41 GERMANY HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 42 GERMANY HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 43 UK HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 44 UK HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 45 UK HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 46 UK HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 47 UK GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 48 UK GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 49 UK HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 50 UK HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 51 FRANCE HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 52 FRANCE HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 53 FRANCE HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 54 FRANCE HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 55 FRANCE GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 56 FRANCE GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 57 FRANCE HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 58 FRANCE HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 59 RUSSIA HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 60 RUSSIA HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 61 RUSSIA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 62 RUSSIA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 63 RUSSIA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 64 RUSSIA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 65 RUSSIA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 66 RUSSIA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 67 SPAIN HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 68 SPAIN HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 69 SPAIN HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 70 SPAIN HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 71 SPAIN GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 72 SPAIN GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 73 SPAIN HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 74 SPAIN HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 75 ITALY HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 76 ITALY HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 77 ITALY HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 78 ITALY HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 79 ITALY GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 80 ITALY GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 81 ITALY HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 82 ITALY HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 83 REST OF EUROPE HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 84 REST OF EUROPE HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 85 REST OF EUROPE HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 86 REST OF EUROPE HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 87 REST OF EUROPE GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 88 REST OF EUROPE GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 89 REST OF EUROPE HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 90 REST OF EUROPE HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 91 KEY INFORMATION – MERCK GROUP
TABLE 92 KEY INFORMATION – TEVA PHARMACEUTICALS INDUSTRIES LTD.
TABLE 93 KEY INFORMATION – IPSEN PHARMA BIOTECH SAS
TABLE 94 KEY INFORMATION – NOVARTIS AG
TABLE 95 KEY INFORMATION – PFIZER, INC.
TABLE 96 KEY INFORMATION – F. HOFFMANN-LA ROCHE LTD.
TABLE 97 KEY INFORMATION – FERRING HOLDINGS SA
TABLE 98 KEY INFORMATION – NOVO NORDISK A/S
TABLE 99 KEY INFORMATION – ELI LILLY AND COMPANY
TABLE 100 KEY INFORMATION – ANHUI ANKE BIOTECHNOLOGY GROUP CO., LTD.
TABLE 1 EUROPE HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 2 EUROPE HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 3 EUROPE HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 4 EUROPE HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 5 EUROPE SMALL FOR GESTATIONAL AGE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 6 EUROPE SMALL FOR GESTATIONAL AGE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 7 EUROPE PRADER-WILLI SYNDROME MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 8 EUROPE PRADER-WILLI SYNDROME MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 9 EUROPE IDIOPATHIC SHORT STATURE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 10 EUROPE IDIOPATHIC SHORT STATURE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 11 EUROPE TURNER SYNDROME MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 12 EUROPE TURNER SYNDROME MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 13 EUROPE GROWTH HORMONE DEFICIENCY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 14 EUROPE GROWTH HORMONE DEFICIENCY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 15 EUROPE GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 16 EUROPE GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 17 EUROPE PEDIATRIC GROWTH HORMONE DEFICIENCY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 18 EUROPE PEDIATRIC GROWTH HORMONE DEFICIENCY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 19 EUROPE ADULT GROWTH HORMONE DEFICIENCY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 20 EUROPE ADULT GROWTH HORMONE DEFICIENCY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 21 EUROPE OTHER APPLICATIONS MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 22 EUROPE OTHER APPLICATIONS MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 23 EUROPE HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 24 EUROPE HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 25 EUROPE RETAIL PHARMACY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 26 EUROPE RETAIL PHARMACY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 27 EUROPE HOSPITAL PHARMACY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 28 EUROPE HOSPITAL PHARMACY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 29 EUROPE SPECIALTY PHARMACY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 30 EUROPE SPECIALTY PHARMACY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 31 EUROPE ONLINE PHARMACY MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 32 EUROPE ONLINE PHARMACY MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 33 EUROPE HUMAN GROWTH HORMONE MARKET BY COUNTRY, 2015 - 2018, USD MILLION
TABLE 34 EUROPE HUMAN GROWTH HORMONE MARKET BY COUNTRY, 2019 - 2025, USD MILLION
TABLE 35 GERMANY HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 36 GERMANY HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 37 GERMANY HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 38 GERMANY HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 39 GERMANY GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 40 GERMANY GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 41 GERMANY HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 42 GERMANY HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 43 UK HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 44 UK HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 45 UK HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 46 UK HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 47 UK GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 48 UK GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 49 UK HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 50 UK HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 51 FRANCE HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 52 FRANCE HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 53 FRANCE HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 54 FRANCE HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 55 FRANCE GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 56 FRANCE GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 57 FRANCE HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 58 FRANCE HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 59 RUSSIA HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 60 RUSSIA HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 61 RUSSIA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 62 RUSSIA HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 63 RUSSIA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 64 RUSSIA GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 65 RUSSIA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 66 RUSSIA HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 67 SPAIN HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 68 SPAIN HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 69 SPAIN HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 70 SPAIN HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 71 SPAIN GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 72 SPAIN GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 73 SPAIN HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 74 SPAIN HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 75 ITALY HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 76 ITALY HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 77 ITALY HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 78 ITALY HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 79 ITALY GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 80 ITALY GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 81 ITALY HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 82 ITALY HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 83 REST OF EUROPE HUMAN GROWTH HORMONE MARKET, 2015 - 2018, USD MILLION
TABLE 84 REST OF EUROPE HUMAN GROWTH HORMONE MARKET, 2019 - 2025, USD MILLION
TABLE 85 REST OF EUROPE HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2015 - 2018, USD MILLION
TABLE 86 REST OF EUROPE HUMAN GROWTH HORMONE MARKET BY APPLICATION, 2019 - 2025, USD MILLION
TABLE 87 REST OF EUROPE GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2015 - 2018, USD MILLION
TABLE 88 REST OF EUROPE GROWTH HORMONE DEFICIENCY APPLICATION MARKET BY TYPE, 2019 - 2025, USD MILLION
TABLE 89 REST OF EUROPE HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2015 - 2018, USD MILLION
TABLE 90 REST OF EUROPE HUMAN GROWTH HORMONE MARKET BY DISTRIBUTION CHANNEL, 2019 - 2025, USD MILLION
TABLE 91 KEY INFORMATION – MERCK GROUP
TABLE 92 KEY INFORMATION – TEVA PHARMACEUTICALS INDUSTRIES LTD.
TABLE 93 KEY INFORMATION – IPSEN PHARMA BIOTECH SAS
TABLE 94 KEY INFORMATION – NOVARTIS AG
TABLE 95 KEY INFORMATION – PFIZER, INC.
TABLE 96 KEY INFORMATION – F. HOFFMANN-LA ROCHE LTD.
TABLE 97 KEY INFORMATION – FERRING HOLDINGS SA
TABLE 98 KEY INFORMATION – NOVO NORDISK A/S
TABLE 99 KEY INFORMATION – ELI LILLY AND COMPANY
TABLE 100 KEY INFORMATION – ANHUI ANKE BIOTECHNOLOGY GROUP CO., LTD.
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 1 METHODOLOGY FOR THE RESEARCH
